Drugs


FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. (AP Photo/Ben Margot, File)
They Got Public Funding to Develop a Coronavirus Treatment. Now They Want to Charge $2,340.

A consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development.

Image via Shutterstock
FDA Slams the Door Shut on Using Hydroxychloroquine to Treat COVID-19

The Food and Drug Administration on Monday announced it was revoking emergency authorization of two malaria drugs touted by President Trump as a possible “‘game changer”’ in the fight against COVID-19.

FILE - This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. (AP Photo/David J. Phillip)
Whistleblower: I Was Fired Over Warnings About Hydroxychloroquine

Dr. Rick Bright alleges he was reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Trump.

Image via Shutterstock
We Might Finally Have an Effective COVID-19 Treatment, But the Economy Is Getting Worse

Word of the drug came as the U.S. government reported that American economic output is shriveling in the biggest and fastest collapse since the Great Depression.

AP Photo/John Locher
‘Serious Heart Rhythm Problems’: FDA Warns Against Using Drugs Trump Promoted

Two studies released this week found that hydroxychloroquine and chloroquine led to more fatalities among coronavirus patients.

AP Photo/Richard Vogel
‘It Was Going to Be the Biggest 4/20 in History’

For dispensaries, 4/20 is usually their Black Friday, when sales soar. Instead, they are reporting up-and-down buying and pondering an uncertain future.

AP Photo/John Locher
Trump Reportedly Has ‘Financial Interest’ in Drug He Says Fights COVID-19

Ignoring medical experts and scientists, Trump has aggressively promoted hydroxychloroquine, while acknowledging that he isn’t a doctor and instead relies on “common sense.”